标题
PI3Kδ Is a Therapeutic Target in Hepatocellular Carcinoma
作者
关键词
-
出版物
HEPATOLOGY
Volume 68, Issue 6, Pages 2285-2300
出版商
Wiley
发表日期
2018-10-10
DOI
10.1002/hep.30307
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Telomere length and reactive oxygen species levels are positively associated with a high risk of mortality and recurrence in hepatocellular carcinoma
- (2018) Eunkyong Ko et al. HEPATOLOGY
- 3′ UTR shortening represses tumor-suppressor genes in trans by disrupting ceRNA crosstalk
- (2018) Hyun Jung Park et al. NATURE GENETICS
- Systematic analysis of telomere length and somatic alterations in 31 cancer types
- (2017) Floris P Barthel et al. NATURE GENETICS
- Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity
- (2016) B. L. Lampson et al. BLOOD
- Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins
- (2016) Yanxia Jin et al. BRITISH JOURNAL OF CANCER
- Targeting PI3K in Cancer: Impact on Tumor Cells, Their Protective Stroma, Angiogenesis, and Immunotherapy
- (2016) K. Okkenhaug et al. Cancer Discovery
- Idelalisib: First-in-Class PI3K Delta Inhibitor for the Treatment of Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, and Follicular Lymphoma
- (2015) Q. Yang et al. CLINICAL CANCER RESEARCH
- O-GlcNAc occurs cotranslationally to stabilize nascent polypeptide chains
- (2015) Yanping Zhu et al. Nature Chemical Biology
- Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
- (2015) Kornelius Schulze et al. NATURE GENETICS
- Response to Idelalisib in a Patient with Stage IV Merkel-Cell Carcinoma
- (2015) Mallory B. Shiver et al. NEW ENGLAND JOURNAL OF MEDICINE
- PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis
- (2015) Min-Sik Lee et al. Nature Communications
- Positive association of long telomeres with the invasive capacity of hepatocellular carcinoma cells
- (2014) Eunkyong Ko et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer
- (2014) Khaled Ali et al. NATURE
- Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
- (2014) Yasushi Totoki et al. NATURE GENETICS
- PI3K and cancer: lessons, challenges and opportunities
- (2014) David A. Fruman et al. NATURE REVIEWS DRUG DISCOVERY
- Telomerase promoter mutations in cancer: an emerging molecular biomarker?
- (2014) João Vinagre et al. VIRCHOWS ARCHIV
- Oxidative stress as a crucial factor in liver diseases
- (2014) Halina Cichoż-Lach WORLD JOURNAL OF GASTROENTEROLOGY
- High levels of p110δ PI3K expression in solid tumor cells suppress PTEN activity, generating cellular sensitivity to p110δ inhibitors through PTEN activation
- (2012) Niki Tzenaki et al. FASEB JOURNAL
- MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma
- (2012) YuXiang Fang et al. HEPATOLOGY
- Reactive Oxygen Species (ROS)––Induced genetic and epigenetic alterations in human carcinogenesis
- (2011) Dominique Ziech et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Altered glycosylation profile of purified plasma ACT from Alzheimer’s disease
- (2011) Manuela Ianni et al. Immunity & Ageing
- Downregulation of catalase by reactive oxygen species via hypermethylation of CpG island II on the catalase promoter
- (2010) Ji Young Min et al. FEBS LETTERS
- Epigenetic Changes Induced by Reactive Oxygen Species in Hepatocellular Carcinoma: Methylation of the E-cadherin Promoter
- (2008) Seung-Oe Lim et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started